BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15290239)

  • 1. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array.
    Zhou X; Mok SC; Chen Z; Li Y; Wong DT
    Hum Genet; 2004 Sep; 115(4):327-30. PubMed ID: 15290239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array.
    Hu N; Wang C; Hu Y; Yang HH; Kong LH; Lu N; Su H; Wang QH; Goldstein AM; Buetow KH; Emmert-Buck MR; Taylor PR; Lee MP
    BMC Genomics; 2006 Nov; 7():299. PubMed ID: 17134496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
    Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
    Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization.
    Lo KC; Bailey D; Burkhardt T; Gardina P; Turpaz Y; Cowell JK
    Genes Chromosomes Cancer; 2008 Mar; 47(3):221-37. PubMed ID: 18050302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
    Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA
    Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analyzing the profile of chromosomal imbalances in esophageal atypical hyperplasia and early stage esophageal squamous cell carcinoma by 250K Snp Array].
    Zhang X; Zhu ZH; Lin P; Yang H; Fu JH; Zhang LJ; Long H; Wen J; Huang XP; Fang Y; Rong TH
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2636-41. PubMed ID: 19080713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma.
    Kurashina K; Yamashita Y; Ueno T; Koinuma K; Ohashi J; Horie H; Miyakura Y; Hamada T; Haruta H; Hatanaka H; Soda M; Choi YL; Takada S; Yasuda Y; Nagai H; Mano H
    Cancer Sci; 2008 Sep; 99(9):1835-40. PubMed ID: 18564138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
    George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
    PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
    Argos M; Kibriya MG; Jasmine F; Olopade OI; Su T; Hibshoosh H; Ahsan H
    Cancer Genet Cytogenet; 2008 Apr; 182(2):69-74. PubMed ID: 18406867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer.
    Tada M; Kanai F; Tanaka Y; Sanada M; Nannya Y; Tateishi K; Ohta M; Asaoka Y; Seto M; Imazeki F; Yoshida H; Ogawa S; Yokosuka O; Omata M
    Cancer Sci; 2010 May; 101(5):1261-9. PubMed ID: 20331625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
    Hawthorn L; Luce J; Stein L; Rothschild J
    BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated analysis tool for analyzing hybridization intensities and genotypes using new-generation population-optimized human arrays.
    Huang MC; Chuang TP; Chen CH; Wu JY; Chen YT; Li LH; Yang HC
    BMC Genomics; 2016 Mar; 17():266. PubMed ID: 27029637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.
    Jänne PA; Li C; Zhao X; Girard L; Chen TH; Minna J; Christiani DC; Johnson BE; Meyerson M
    Oncogene; 2004 Apr; 23(15):2716-26. PubMed ID: 15048096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.
    Ching HC; Naidu R; Seong MK; Har YC; Taib NA
    Int J Oncol; 2011 Sep; 39(3):621-33. PubMed ID: 21687935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms.
    Gunnarsson R; Staaf J; Jansson M; Ottesen AM; Göransson H; Liljedahl U; Ralfkiaer U; Mansouri M; Buhl AM; Smedby KE; Hjalgrim H; Syvänen AC; Borg A; Isaksson A; Jurlander J; Juliusson G; Rosenquist R
    Genes Chromosomes Cancer; 2008 Aug; 47(8):697-711. PubMed ID: 18484635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.